211 related articles for article (PubMed ID: 21447190)
1. Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke.
Nakase T; Yoshioka S; Suzuki A
BMC Neurol; 2011 Mar; 11():39. PubMed ID: 21447190
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction.
Mishina M; Komaba Y; Kobayashi S; Tanaka N; Kominami S; Fukuchi T; Mizunari T; Hamamoto M; Teramoto A; Katayama Y
Neurol Med Chir (Tokyo); 2005 Jul; 45(7):344-8; discussion 348. PubMed ID: 16041179
[TBL] [Abstract][Full Text] [Related]
3. Effects of edaravone on muscle atrophy and locomotor function in patients with ischemic stroke: a randomized controlled pilot study.
Naritomi H; Moriwaki H; Metoki N; Nishimura H; Higashi Y; Yamamoto Y; Yuasa H; Oe H; Tanaka K; Saito K; Terayama Y; Oda T; Tanahashi N; Kondo H;
Drugs R D; 2010; 10(3):155-63. PubMed ID: 20945946
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
Tanaka M
Nihon Yakurigaku Zasshi; 2002 May; 119(5):301-8. PubMed ID: 12061142
[TBL] [Abstract][Full Text] [Related]
5. Edaravone offers neuroprotection for acute diabetic stroke patients.
Zheng J; Chen X
Ir J Med Sci; 2016 Nov; 185(4):819-824. PubMed ID: 26597952
[TBL] [Abstract][Full Text] [Related]
6. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
Isahaya K; Yamada K; Yamatoku M; Sakurai K; Takaishi S; Kato B; Hirayama T; Hasegawa Y
J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):102-7. PubMed ID: 21215657
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the free radical scavenger, edaravone, for motor palsy of acute lacunar infarction.
Ohta Y; Takamatsu K; Fukushima T; Ikegami S; Takeda I; Ota T; Goto K; Abe K
Intern Med; 2009; 48(8):593-6. PubMed ID: 19367054
[TBL] [Abstract][Full Text] [Related]
8. Investigation of effect of edaravone on ischemic stroke.
Ishibashi A; Yoshitake Y; Adachi H
Kurume Med J; 2013; 60(2):53-7. PubMed ID: 24291782
[TBL] [Abstract][Full Text] [Related]
9. Does functional outcome in acute ischaemic stroke patients correlate with the amount of free-radical scavenger treatment? A retrospective study of edaravone therapy.
Unno Y; Katayama M; Shimizu H
Clin Drug Investig; 2010; 30(3):143-55. PubMed ID: 20155987
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
Tanahashi N; Yamaguchi T; Awano H; Matsuda H
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1302-1310. PubMed ID: 29373227
[TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
Kamouchi M; Sakai H; Kiyohara Y; Minematsu K; Hayashi K; Kitazono T
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e470-6. PubMed ID: 23800495
[TBL] [Abstract][Full Text] [Related]
12. Effect of edaravone on acute brainstem-cerebellar infarction with vertigo and sudden hearing loss.
Inoue Y; Yabe T; Okada K; Nakamura Y
Auris Nasus Larynx; 2014 Jun; 41(3):303-6. PubMed ID: 24176488
[TBL] [Abstract][Full Text] [Related]
13. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
Yamaguchi T; Awano H; Matsuda H; Tanahashi N;
J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):756-765. PubMed ID: 27887792
[TBL] [Abstract][Full Text] [Related]
14. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
Shinohara Y; Saito I; Kobayashi S; Uchiyama S
Cerebrovasc Dis; 2009; 27(5):485-92. PubMed ID: 19321945
[TBL] [Abstract][Full Text] [Related]
15. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.
Wada T; Yasunaga H; Inokuchi R; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
J Neurol Sci; 2014 Oct; 345(1-2):106-11. PubMed ID: 25085762
[TBL] [Abstract][Full Text] [Related]
16. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.
Tsuruoka A; Atsumi C; Mizukami H; Imai T; Hagiwara Y; Hasegawa Y
J Stroke Cerebrovasc Dis; 2014; 23(10):2894-2899. PubMed ID: 25282183
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease.
Kikuchi K; Tancharoen S; Takeshige N; Yoshitomi M; Morioka M; Murai Y; Tanaka E
Int J Mol Sci; 2013 Jul; 14(7):13909-30. PubMed ID: 23880849
[TBL] [Abstract][Full Text] [Related]
18. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.
Toyoda K; Fujii K; Kamouchi M; Nakane H; Arihiro S; Okada Y; Ibayashi S; Iida M
J Neurol Sci; 2004 Jun; 221(1-2):11-7. PubMed ID: 15178207
[TBL] [Abstract][Full Text] [Related]
19. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters.
Edaravone Acute Infarction Study Group
Cerebrovasc Dis; 2003; 15(3):222-9. PubMed ID: 12715790
[TBL] [Abstract][Full Text] [Related]
20. [A case of stroke-like episode of MELAS of which progressive spread would be prevented by edaravone].
Maeda K; Tatsumi M; Tahara M; Murata Y; Kawai H; Yasuda H
Rinsho Shinkeigaku; 2005 Jun; 45(6):416-21. PubMed ID: 16022465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
